NCT00893685.

Methods	Study design: multi‐centre, open‐label, parallel individual randomised controlled trial Duration: 130 weeks Setting: healthcare systems
Participants	Population: 300 adults recruited from Denmark, Estonia, Germany, Italy, Spain, Sweden Baseline characteristics: unknown Inclusion criteria: < 65 years; diagnosis of CHF, DM, or COPD Exclusion criteria: unable to use study equipment, dependent on others for daily living, diagnosis of dementia, impaired language, no signed informed consent, no access to ISDN or DSL service
Interventions	Measurements taken at baseline and at 15 and 30 months Treatment arms Home television‐based teleconferencing system Daily monitoring sent to central monitoring unit
Outcomes	Primary outcomes: SF‐36 questionnaire Secondary outcomes: hospital length of stay, transfer to elderly home, number of hospitalisations, HADS, death, injury, ambulance transport, emergency department visits, home visits by nurses, consults with GP or specialists
Notes	Funding: Health Information Management, Belgium Other identifier:NCT00893685